Skip to main content

Table 1 In vitro medication delivery through the test VHC with small/medium face masks at different flow rates and holding times

From: 5th Pediatric Allergy and Asthma Meeting (PAAM)

Flow rate and corresponding age

Mask

Holding time, s

Mean medication delivery through test VHC, μg/dose

Body weight 50th percentile, kg

Medication delivered per dose, ng/kg*

4.9 L/min (6–12 months)

Small

0

0.85 (± 0.04)

7.5–9.9

86–113

2

0.86 (± 0.14)

87–115

5

0.55 (± 0.16)

56–73

10

0.62 (± 0.02)

63–83

8.0 L/min (2–5 years)

Medium

0

0.74 (± 0.05)

12.3–18.0

41–60

2

0.93 (± 0.05)

52–76

5

0.72 (± 0.07)

40–59

10

0.57 (± 0.05)

32–46

12.0 L/min (> 5 years)

Medium

0

1.16 (± 0.07)

18.0

64

2

0.96 (± 0)

53

5

0.78 (± 0.18)

43

10

0.61 (± 0.02)

34

  1. Data corresponding to age group 13–23 months are not available
  2. *Inhalation of 2.5 µg tiotropium Respimat® (as two actuations) in a 70 kg adult without use of the test VHC and face mask delivers approximately 2.5 μg or 36 ng/kg